Approval · Notice of Compliance 21833 · 2019
DEXIRON: Notice of Compliance 21833
Issued February 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21833
- Date
- February 5, 2019
- Company
- American Regent, IncShirley, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEXIRON | 02205963 | Cancelled Post Market |
Medicinal ingredients
- IRON DEXTRAN 50 MG per ML